All stock lists
Milestone Pharmaceuticals Inc. (NASDAQ:MIST)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
$0.52-$0.14 (-20.63%)
Market cap
$64.7M
Insider Score
Health Score
Analyst consensus
Listed since
May 9, 2019
Website
Insider Score
––Not scored
MIST Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
MIST analyst forecast
MIST analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
MIST 12-month price target
$8.00+1438.5% upsideaverage of 2 firms
$8.00High
$8.00Low
Best analysts covering MIST
- TD Cowen100%success rate · +5.3% avg return · 1 call
- HC Wainwright & Co.44%success rate · -11.1% avg return · 18 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MIST analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| HC Wainwright & Co. | Buy | $8.00 | +210.7% | Reiterated | 2026-09-03 | |
| Wells Fargo | Overweight | $8.00 | +241.9% | Reiterated | 2026-05-14 | |
| — | TD Cowen | Buy | — | — | Upgraded | 2025-12-15 |
MIST earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-20 | -$0.18 | -$0.16 | $37.5M | $1.5M |
| 2026-05-13 | $0.06 | -$0.20 | $30.1M | $238K |
| 2026-08-12 | -$0.20 | -$0.21 | $817K | $559K |
| 2026-11-13 | -$0.22 | -$0.18 | $1.0M | $3.0M |
| 2027-03-19Upcoming | -$0.22 | — | $1.7M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.